|
|
Publications - Newletters and Briefing Notes
Chemistry & Life Sciences
Features:
- Another Fine Mess! - Confusion about New Matter in Europe, and Beware of Amendments suggested by the EPO!
- English Court Considers Infringement of Claims to "Isolated" DNA
- Strict EPO Test for Priority Confirmed in Biotech Case
- Introduced Disclaimer Not Available Where Prior Art is Unclear
- Recombing Parts of a More Complex Definition of a Composition Adds New Matter
 download
Features:
- Happy New Year!
- Croatia and Norway Join the EPC
- How Predictable is One Anti-cancer Activity from Others?
- Questions about SPC Applications Referred to ECJ
- EU Joins the Hague Agreement on Industrial Designs
- EC Regulations on Paediatric Medicines and Compulsory Licences
download
Features:
- London Agreement to Come into Force
- EPO Board of Appeal Clarifies Requirements for Internet Prior Art
- More Unclear or Insufficiently Described Parameters Cause Problems for Patentees/Applicants
- Start Date of EPC2000 is 13 December 2007
download
Features:
- Implementation of EU Biotech Directive Now Complete
- Are SPCs Available for Second/Subsequent Medical Uses?
- Countdown to EPC2000
- Norway to Join the EPC
- EPO to Stop Private Searches
- Stay Refused in Pharmaceutical Case of Parallel EPO and UK Proceedings
download
Features:
- Liberal Divisional Practice Continues at the EPO
- UK Patent Damages, Account or Costs Not Negated by Later Revocation in the EPO
- More European Patents Lost through Use of Unclear Parameters
- Appellant-Patentee's General Right to Revert to Claims as Granted Affirmed
- Example Written in the Present Tense Supportive of Inventive Step in Biotech Case
download
Features:
- New Associate in the Chemical and Life Sciences Group
- UK Patent Office Name Change
- Pharmaceutical Repackaging/Relabelling Conditions Clarified
- Claim Combinations in the EPO Need Clear Basis, Preferably in the Original Dependencies
- Italy - Official Fees for Intellectual Property Rights
- Countdown to EPC2000
- Two New Referrals to the EPO Enlarged Board of Appeal
download
Features:
- US Priority Documents to be Obtained Directly by the EPO
- Countdown to EPC 2000
- Malta Becomes the 32nd EPC Contracting State
- Must Naturally Occurring Nucleotide Sequences be Claimed as "Isolated" in Europe?
- First Decision in G 1/05 (EPO Divisional Practice)
- Patentee Prevented from Reversing, at Oral Proceedings, an earlier Admission of Prior Publication
- Promotion of an SPC- or Patent-protected Product Infringes in Germany
download
Features:
- Gowers Review of IP in the United Kingdom Published
- Clarity of Relative Expressions in EPO Claims
- Two More Salutary Parameter Decisions from the EPO
- A "Method of Diagnostic Imaging" is Patentable If the Diagnostic Step is Not Specified
download
Features:
- Lipitor (TM) Appeal and Cross-Appeal Dismissed
- "Comprises" Not Always Amendable To "Consisting Essentially Of" in the EPO
- "Characterised as..." Not Clear in EPO Composition Claims
- A Disclosed Embodiment Provides Basis for a Corresponding Specific Disclaimer
download
Features:
- Patent Cross-Border Injunctions Held Up in Customs, and Torpedoes Torpedoed
- Update on Implementation of the EC IP Enforcement Directive
- Purely Psychological Research Tool Inventions Not Patentable in the EPO
- First UK Patent Office Opinion Issued in Chem/Pharma/Bio Field
download
Features:
- Report on Implementation of EC IP Enforcement Directive - "Knowledge" Test Introduced into the Assessment of Damages
- Interpretation of EPC Rule 23d(c) Referred to Enlarged Board
- SPCs Not Available for Delayed-Release Formulations of Old Actives
- Verbatim Incorporation of Full Cross-Referenced Document Adds New Matter
download
Features:
- Progress Report on EPO’s Review of Divisional Practice
- It’s Enough to Make You Swear!
- EPO Examines “First Application” Status in a Priority Analysis
download
Features:
- A Relevant Subsidiary Business in a Corporate Group Should Oppose in its Own Name
- Viagra Opposition Concludes in the EPO Board of Appeal
- Biotech Patentability Questions to be Referred to EPO Enlarged Board
- Examples that Become Excluded by a Disclaimer are Relevant to Support the Claims
- Burden of Proof in Crystalline Form Cases Favourable to Applicants/Patentees
download
Features:
- New Associate
- Update on Implementation of the European Bolar Exemption Provisions
- "Diagnostic Methods" Narrowly Interpreted in European Law
- Four UK Patent Office Opinions Issued up to 15 February 2006
- EPC 2000 Start Date Established
download
Features:
- Progress Report on Implementation of the European-style "Bolar Exemption"
- EPO Board of Appeal 3.3.4 Approves Swiss Claims in "Administration Protocol" Case
- Divisional Practice to be Reviewed by EPO Enlarged Board of Appeal
- UK Patent Office Revises Interpretation of Product-by-Process Claims
download
Features:
- "Enabling Disclosure" Considered in a "Crystalline Form" Case in the UK
- Lipitor™ UK Master Patent Construed Broadly in Challenge by Ranbaxy, but later Salt Patent Held Invalid - Observations on the Patentability of Selection Inventions in the UK
download
Features:
- Germany Implements EU Biotechnology Directive with a Twist
- Claims defined by Parameters at Risk of Invalidity in the EPO
- Suspension of European Patent Application Reviewed in Entitlement Dispute
download
Features:
- Welcome to www.haseltinelake.com
- Next Stage of Implementation of the UK Patents Act 2004
- Start of UK Patent Office Opinions on Infringement or Validity
download
Features:
- EPO still inconsistent on requiring supporting data in the application in second medical use case
- Oncomouse decision issued by EPO Board of Appeal 3.3.8
- Methods of treatment of the human or animal body by surgery are patentable in some circumstances
- Supplementary Protection Certificates (SPCs) – the Liechtenstein question
download
Features:
- European patent office moves to stricter requirements for divisional applications
- Costs awarded in EPO opposition proceedings
- Recent EPO cases on novelty
download
Features:
- EPO approves claims to an old therapeutic use defined by a new mode of action
- Time limit for completing EPO grant formalities to be non-extendable
- German Federal Court rules on claim construction
- EPO to cease paper publication of patent applications and patents
download
Features:
- UK patent law revision – update
- UK patent office opinions – introduction
- EPO questions use of elaborate visual aids at oral proceedings
- Amicus brief filed in EPO’s review of prohibition on diagnostic methods
download
Features:
- The Kirin Amgen decision
- House of lords rules on sufficiency and claim construction in biotech case
download
Features:
- UK patent law revision
- European-style “Bolar Exemption” to be introduced
- EPO Board of Appeal develops novelty test in disclaimer case
download
Features:
- Patentability of diagnostic methods referred to enlarged Board of Appeal - G1/04
download
|
|
